Coverage with Influenza, Respiratory Syncytial Virus, and COVID-19 Vaccines Among Nursing Home Residents - National Healthcare Safety Network, United States, November 2024.

IF 25.4 1区医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH

MMWR. Morbidity and mortality weekly report Pub Date : 2024-11-21 DOI:10.15585/mmwr.mm7346a2

Hannah E Reses, George Segovia, Heather Dubendris, Kira Barbre, Sushmitha Ananth, Brynn Lape-Newman, Emily Wong, Molly Stillions, Theresa Rowe, Elizabeth Mothershed, Erika Wallender, Evelyn Twentyman, Ryan E Wiegand, Pragna Patel, Andrea Benin, Jeneita M Bell

{"title":"Coverage with Influenza, Respiratory Syncytial Virus, and COVID-19 Vaccines Among Nursing Home Residents - National Healthcare Safety Network, United States, November 2024.","authors":"Hannah E Reses, George Segovia, Heather Dubendris, Kira Barbre, Sushmitha Ananth, Brynn Lape-Newman, Emily Wong, Molly Stillions, Theresa Rowe, Elizabeth Mothershed, Erika Wallender, Evelyn Twentyman, Ryan E Wiegand, Pragna Patel, Andrea Benin, Jeneita M Bell","doi":"10.15585/mmwr.mm7346a2","DOIUrl":null,"url":null,"abstract":"<p><p>Nursing home residents are at elevated risk for severe complications from respiratory viruses, including SARS-CoV-2, influenza, and respiratory syncytial virus (RSV). Nursing homes are required to report COVID-19 vaccination coverage and can voluntarily report influenza and RSV vaccination coverage among residents to CDC's National Healthcare Safety Network. The purpose of this study was to assess COVID-19, influenza, and RSV vaccination coverage among nursing home residents early in the 2024-25 respiratory virus season. As of November 10, 2024, 29.7% of nursing home residents had received a 2024-2025 COVID-19 vaccine. Among residents at facilities that elected to report vaccination against influenza (59.4% of facilities) and RSV (51.8% of facilities), 58.4% had received influenza vaccination, and 17.9% had received RSV vaccination. Vaccination coverage varied by U.S. Department of Health and Human Services region, social vulnerability index level, and facility size. Addressing low coverage with COVID-19, influenza, and RSV vaccines is a priority to protect residents who are susceptible to severe outcomes associated with respiratory illnesses.</p>","PeriodicalId":18637,"journal":{"name":"MMWR. Morbidity and mortality weekly report","volume":"73 46","pages":"1052-1057"},"PeriodicalIF":25.4000,"publicationDate":"2024-11-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"MMWR. Morbidity and mortality weekly report","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.15585/mmwr.mm7346a2","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}

引用次数: 0

Abstract

Nursing home residents are at elevated risk for severe complications from respiratory viruses, including SARS-CoV-2, influenza, and respiratory syncytial virus (RSV). Nursing homes are required to report COVID-19 vaccination coverage and can voluntarily report influenza and RSV vaccination coverage among residents to CDC's National Healthcare Safety Network. The purpose of this study was to assess COVID-19, influenza, and RSV vaccination coverage among nursing home residents early in the 2024-25 respiratory virus season. As of November 10, 2024, 29.7% of nursing home residents had received a 2024-2025 COVID-19 vaccine. Among residents at facilities that elected to report vaccination against influenza (59.4% of facilities) and RSV (51.8% of facilities), 58.4% had received influenza vaccination, and 17.9% had received RSV vaccination. Vaccination coverage varied by U.S. Department of Health and Human Services region, social vulnerability index level, and facility size. Addressing low coverage with COVID-19, influenza, and RSV vaccines is a priority to protect residents who are susceptible to severe outcomes associated with respiratory illnesses.

查看原文本刊更多论文

2024 年 11 月美国养老院居民的流感、呼吸道合胞病毒和 COVID-19 疫苗接种率 - 美国国家医疗安全网。

疗养院居民因呼吸道病毒（包括 SARS-CoV-2、流感和呼吸道合胞病毒 (RSV)）引起严重并发症的风险较高。疗养院必须报告 COVID-19 疫苗的接种率，并可自愿向疾病预防控制中心的国家医疗安全网络报告居民中流感和 RSV 疫苗的接种率。本研究旨在评估 COVID-19、流感和 RSV 疫苗在 2024-25 年呼吸道病毒季节初期在疗养院居民中的接种率。截至 2024 年 11 月 10 日，29.7% 的疗养院居民接种了 2024-2025 年 COVID-19 疫苗。在选择报告流感疫苗接种情况（59.4% 的机构）和 RSV 疫苗接种情况（51.8% 的机构）的机构中，58.4% 的居民接种过流感疫苗，17.9% 的居民接种过 RSV 疫苗。疫苗接种覆盖率因美国卫生与公众服务部的地区、社会脆弱性指数水平和设施规模而异。解决 COVID-19、流感和 RSV 疫苗接种覆盖率低的问题是保护那些容易因呼吸道疾病导致严重后果的居民的当务之急。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

MMWR. Morbidity and mortality weekly report PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH -

CiteScore

65.40

自引率

0.90%

发文量

309

期刊介绍： The Morbidity and Mortality Weekly Report (MMWR ) series is prepared by the Centers for Disease Control and Prevention (CDC). Often called “the voice of CDC,” the MMWR series is the agency’s primary vehicle for scientific publication of timely, reliable, authoritative, accurate, objective, and useful public health information and recommendations. MMWR readership predominantly consists of physicians, nurses, public health practitioners, epidemiologists and other scientists, researchers, educators, and laboratorians.